Company: SMNR
Filing Date: 2025-12-03
Form Type: S-8
Source: 0001193125-25-306969
Chunk: 5

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: S-8
Chunk 5
---
 Equity Incentive Plan.                                    |
| 99.3*   |     | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the Semnur Pharmaceuticals, Inc. 2025 Equity Incentive Plan.      |
| 99.4*   |     | Form of Semnur Pharmaceuticals, Inc. 2025 Employee Stock Purchase Plan.                                                                                            |
| 99.5*   |     | Semnur Pharmaceuticals, Inc. 2025 Inducement Plan.                                                                                                                 |
| 99.6*   |     | Form of Stock Option Grant Notice and Stock Option Agreement under the Semnur Pharmaceuticals, Inc. 2025 Inducement Plan.                                          |
| 99.7*   |     | Form of Restricted Stock Unit Award Grant Notice and Award Agreement under the Semnur Pharmaceuticals, Inc. 2025 Inducement Plan.                                  |
| 107*    |     | Filing Fee Table                                                                                                                                                   |

| * | Filed herewith. |

II-3

ITEM 9. UNDERTAKINGS.

(a) The Registrant hereby undertakes:

(1) To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i) To include
any prospectus required by Section 10(a)(3) of the Securities Act;

(ii) To reflect in the prospectus any facts or events arising
after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement.
Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set
forth in the “Calculation of Registration Fee” table in the effective registration statement; and

(iii) To include any
material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

Provided, however, that:

(A) paragraphs (a)(l)(i) and (a)(l)(